reviewTop 1% cited
Structure-Immunogenicity Relationships of Therapeutic Proteins
Pharmaceutical Research · 2004 · Vol. 21(6) · pp. 897–903
Suzanne Hermeling✉(Pharmo Institute)Daan J.A. Crommelin(Pharmo Institute)Huub Schellekens(Utrecht University)Wim Jiskoot(Pharmo Institute)
Monoclonal and Polyclonal Antibodies ResearchProtein purification and stabilityViral Infectious Diseases and Gene Expression in InsectsImmunogenicityPEGylationAntibodyImmune systemProtein structureBiologyGlycosylationRecombinant DNAChemistryBiochemistry
MeSH terms
AnimalsHumansImmune ToleranceNetherlandsRecombinant ProteinsStructure-Activity RelationshipProtein Engineering
Citations
617
FWCI
17.13
field-weighted impact
References
47
Percentile
100%
vs. same field & year
Citations per year
Cited by
Effects of glycosylation on the stability of protein pharmaceuticals
Journal of Pharmaceutical Sciences · 2008 · 636 citations
Properties, production, and applications of camelid single-domain antibody fragments
Applied Microbiology and Biotechnology · 2007 · 795 citations
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
Pharmaceutical Research · 2008 · 1,173 citations
Antibody Structure, Instability, and Formulation
Journal of Pharmaceutical Sciences · 2006 · 923 citations
Stability of Protein Pharmaceuticals: An Update
Pharmaceutical Research · 2010 · 1,076 citations
References
Protein glycosylation
European Journal of Biochemistry · 1993 · 829 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
